Status:
COMPLETED
Immunologic Memory (Supp. of ATN 024)
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
National Institute of Mental Health (NIMH)
Conditions:
HIV Infections
Eligibility:
All Genders
12-25 years
Phase:
PHASE4
Brief Summary
This is an exploratory, laboratory-based evaluation of cellular immune response to immunization with hepatitis B surface antigen in HIV-infected and HIV-uninfected adolescents. This is a substudy of A...
Detailed Description
This substudy will enroll volunteers from participants of ATN 024 and ATN 025. Participants in ATN 024 are HIV-infected youths aged 12-24 years while participants in ATN 025 are HIV-uninfected youths ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Subjects that are eligible for participation in ATN 024 and ATN 025 are eligible for ATN 048. Subjects consented for ATN 024 or ATN 025 should be consented for ATN 048 at the same time. A written informed assent/consent must be obtained from the subject along with written parental/legal guardian permission as determined by the local IRB before any study-related procedures are performed.
Exclusion
Key Trial Info
Start Date :
August 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2007
Estimated Enrollment :
95 Patients enrolled
Trial Details
Trial ID
NCT00142753
Start Date
August 1 2005
End Date
November 1 2007
Last Update
February 28 2017
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Childrens Hosp of Los Angeles
Los Angeles, California, United States, 90027
2
University of California at San Francisco
San Franciso, California, United States, 94118
3
Children's Hosp Natinal Med Center
Washington D.C., District of Columbia, United States, 20010
4
Tulane Med Center
New Orleans, Louisiana, United States, 70112